中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

134 records (took 0.029 seconds)

    METHODS AND SYSTEMS TO TRAIN ARTIFICIAL INTELLIGENCE MODULES
    1.
    发明申请
    METHODS AND SYSTEMS TO TRAIN ARTIFICIAL INTELLIGENCE MODULES 审中-公开

    公开(公告)号：WO2021195845A1

    公开(公告)日：2021-10-07

    申请号：PCT/CN2020/082103

    申请日：2020-03-30

    Applicant: ORANGE ,  WANG, Xiaoyu Richard ,  ZHENG, Tao ,  WANG, Xin

    Inventor： WANG, Xiaoyu Richard ,  ZHENG, Tao ,  WANG, Xin

    IPC: G06N3/02 ,  G06N3/0454 ,  G06N3/08

    Abstract: Methods and systems to train artificial intelligence modules protect privacy of sensitive data by virtue of the fact that the data source (1) extracts blocks of partial data from the source item of content (11) and distributes the extracted partial data to a plurality of processing nodes (5) in an intermediate processing system (2). The processing nodes each perform an initial portion of the training process, for example by performing a convolution of the partial data, to produce a partial model (PM). The partial models (PM) are transmitted to a merging module (10) which amalgamates them and completes the training process to generate a global model (GM) for the AI task.

    SYSTEM, APPARATUS AND METHOD FOR SHARING A SCREEN HAVING MULTIPLE VISUAL COMPONENTS
    3.
    发明申请
    SYSTEM, APPARATUS AND METHOD FOR SHARING A SCREEN HAVING MULTIPLE VISUAL COMPONENTS 审中-公开
    用于共享具有多个视觉组件的画面的系统，装置和方法

    公开(公告)号：WO2014113684A1

    公开(公告)日：2014-07-24

    申请号：PCT/US2014/012065

    申请日：2014-01-17

    Applicant: FUTUREWEI TECHNOLOGIES, INC. ,  YU, Haoping ,  WANG, Xin

    Inventor： YU, Haoping ,  WANG, Xin

    IPC: H04N19/00

    CPC classification number: H04L65/403 ,  H04L65/607 ,  H04L69/04 ,  H04N19/27

    Abstract: Embodiments of the invention provide a screen sharing technology including a local computing device and a remote computing device. The local computing device compresses pixel data captured from a frame buffer of the local computing device into a video stream. When the local computing device determines that a video visual component is to be displayed, it obtains compressed data for the video visual component, location information and temporal information. The remote computing device decodes the compressed data and the video stream in different decoder and displays the video stream and compressed data on its monitor according to the temporal information and location information. As such, the embodiment described above leads to better coding efficiency, better coding quality, and lower bit rate.

    Abstract translation: 本发明的实施例提供一种包括本地计算设备和远程计算设备的屏幕共享技术。 本地计算设备将从本地计算设备的帧缓冲器捕获的像素数据压缩成视频流。 当本地计算设备确定要显示视频可视组件时，它获得用于视频可视组件，位置信息和时间信息的压缩数据。 远程计算设备对不同解码器中的压缩数据和视频流进行解码，并根据时间信息和位置信息在监视器上显示视频流和压缩数据。 因此，上述实施例导致更好的编码效率，更好的编码质量和较低的比特率。

    SYSTEM AND METHOD FOR PREDICTING AMBIENT TEMPERATURE IN A FLUID ANALYTE METER
    6.
    发明申请
    SYSTEM AND METHOD FOR PREDICTING AMBIENT TEMPERATURE IN A FLUID ANALYTE METER 审中-公开
    用于预测流体分析仪计量器环境温度的系统和方法

    公开(公告)号：WO2010040090A3

    公开(公告)日：2010-07-01

    申请号：PCT/US2009059430

    申请日：2009-10-02

    Applicant: BAYER HEALTHCARE LLC ,  FARRELL JOHN ,  LIEBER HARRIS ,  SUN HOI-CHEONG STEVE ,  WU MU ,  CHEN JUN ,  GOFMAN IGOR ,  REYNOLDS JEFFERY S ,  WANG XIN ,  STEFKOVIC GREG ,  HARRISON BERN

    Inventor： FARRELL JOHN ,  LIEBER HARRIS ,  SUN HOI-CHEONG STEVE ,  WU MU ,  CHEN JUN ,  GOFMAN IGOR ,  REYNOLDS JEFFERY S ,  WANG XIN ,  STEFKOVIC GREG ,  HARRISON BERN

    IPC: A61B5/00 ,  G01N33/487

    CPC classification number: A61B5/14532 ,  A61B2562/0295 ,  G01K7/427 ,  G01N33/48785

    Abstract: A system for a meter configured to determine an analyte concentration of a fluid sample includes a housing and a temperature sensor disposed within the housing. The system also includes a processor configured to receive temperature data from the temperature sensor upon the meter entering one of a charge state and a discharge state. The processor is further configured to predict a temperature value that approximates the ambient temperature outside of the housing. The predicted temperature value is based on historical temperature data received from the temperature sensor such that the predicted temperature value remains constant if a recently received temperature value remains within predetermined upper and lower temperature thresholds and the recently received temperature value exceeds the at least one predicted temperature value.

    Abstract translation: 用于被配置为确定流体样本的分析物浓度的流量计的系统包括外壳和设置在外壳内的温度传感器。 该系统还包括处理器，该处理器被配置成在仪表进入充电状态和放电状态之一时从温度传感器接收温度数据。 处理器还被配置为预测接近壳体外部的环境温度的温度值。 预测温度值基于从温度传感器接收的历史温度数据，使得如果最近接收的温度值保持在预定的上限温度阈值和下限温度阈值内并且最近接收的温度值超过至少一个预测温度，则预测温度值保持恒定 值。

    GENE SIGNATURE FOR PREDICTING PROGNOSIS OF PATIENTS WITH SOLID TUMORS
    7.
    发明申请
    GENE SIGNATURE FOR PREDICTING PROGNOSIS OF PATIENTS WITH SOLID TUMORS 审中-公开
    用于预测患有固体肿瘤的患者的基因标志

    公开(公告)号：WO2010054379A2

    公开(公告)日：2010-05-14

    申请号：PCT/US2009/063883

    申请日：2009-11-10

    Applicant: THE UNITED STATES OF AMERICA, as represensted by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES ,  WANG, Xin, Wei ,  ROESSLER, Stephanie, K.

    Inventor： WANG, Xin, Wei ,  ROESSLER, Stephanie, K.

    IPC: C12Q1/68

    CPC classification number: C07K16/18 ,  C12N15/113 ,  C12N15/85 ,  C12N15/86 ,  C12Q1/6841 ,  C12Q1/6886 ,  C12Q2600/112 ,  C12Q2600/118 ,  C12Q2600/136 ,  C12Q2600/158 ,  G01N33/57415 ,  G01N33/57438 ,  G01N2800/50

    Abstract: Disclosed herein is a driver gene signature for predicting survival in patients with solid tumors, such as hepatocellular carcinoma (HCC) and breast cancer. The gene signature includes ten tumor-associated genes, SH2D4A, CCDC25, ELP3, DLCl, PROSC, SORBS3, HNRPD, PAQR3, PHF17 and DCK. A decrease in DNA copy number or mRNA expression of SH2D4A, CCDC25, ELP3, DLCl, PROSC and S0RBS3 in solid tumors is associated with a poor prognosis, while a decrease in DNA copy number or mRNA expression of HNRPD, PAQR3, PHF17 and DCK in solid tumors is associated with a good prognosis. Thus, provided herein is a method of predicting the prognosis of a patient diagnosed with HCC or breast cancer by detecting expression of one of more tumor-associated genes in a tumor sample and comparing expression of the one or more tumor-associated genes in the tumor sample to a control. Also provided is a method of treating a patient diagnosed with HCC or breast cancer by administering a therapeutically effective amount of an agent that alters expression or activity of one or more of the disclosed tumor- associated genes. Further provided are arrays comprising probes or antibodies specific for a plurality of tumor-associated genes or proteins.

    Abstract translation: 本文公开了用于预测实体瘤患者如肝细胞癌（HCC）和乳腺癌的存活的驱动基因特征。 基因特征包括10个肿瘤相关基因SH2D4A，CCDC25，ELP3，DLC1，PROSC，SORBS3，HNRPD，PAQR3，PHF17和DCK。 实体瘤中SH2D4A，CCDC25，ELP3，DLC1，PROSC和S0RBS3的DNA拷贝数或mRNA表达降低与预后不良相关，而HNRPD，PAQR3，PHF17和DCK的DNA拷贝数或mRNA表达降低 实体瘤有良好的预后。 因此，本文提供了通过检测肿瘤样品中更多肿瘤相关基因之一的表达并比较肿瘤中一种或多种肿瘤相关基因的表达来预测诊断为HCC或乳腺癌的患者的预后的方法 样本到控件。 还提供了通过施用治疗有效量的改变一种或多种所公开的肿瘤相关基因的表达或活性的药剂来治疗被诊断患有HCC或乳腺癌的患者的方法。 还提供了包含针对多个肿瘤相关基因或蛋白质特异的探针或抗体的阵列。

    ELECTROSTATIC SPINNING ASSEMBLY
    8.
    发明申请
    ELECTROSTATIC SPINNING ASSEMBLY 审中-公开
    静电纺丝组件

    公开(公告)号：WO2010043002A1

    公开(公告)日：2010-04-22

    申请号：PCT/AU2009/001373

    申请日：2009-10-14

    Applicant: DEAKIN UNIVERSITY ,  LIN, Tong ,  WANG, Xungai ,  WANG, Xin ,  NIU, Haitao

    Inventor： LIN, Tong ,  WANG, Xungai ,  WANG, Xin ,  NIU, Haitao

    IPC: D01D5/00 ,  D01D5/18

    CPC classification number: D01D5/0069

    Abstract: A spinneret for producing nanofibres from a viscous liquid using electrostatic spinning in an electric field is described. The spinneret includes one or more narrow annular bodies radially centred about and axially spaced along a central axis. The annular bodies may be discs, rings, or coils.

    Abstract translation: 描述了一种用于在电场中使用静电纺丝从粘性液体生产纳米纤维的喷丝头。 喷丝头包括一个或多个沿着中心轴径向中心并沿轴向间隔开的窄环形体。 环形体可以是盘，环或线圈。

    USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY
    9.
    发明申请
    USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY 审中-公开
    使用MIR-26家族作为肝细胞癌的预测标记和治疗的反应

    公开(公告)号：WO2009152300A1

    公开(公告)日：2009-12-17

    申请号：PCT/US2009/046999

    申请日：2009-06-11

    Applicant: THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES ,  THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION ,  FUDAN UNIVERSITY ,  WANG, Xin, W. ,  JI, Junfang ,  CROCE, Carlo, M. ,  SUN, Hui-chuan ,  TANG, Zhao-you

    Inventor： WANG, Xin, W. ,  JI, Junfang ,  CROCE, Carlo, M. ,  SUN, Hui-chuan ,  TANG, Zhao-you

    IPC: A61K31/70 ,  C12Q1/68

    CPC classification number: A61K31/70 ,  A61K38/212 ,  C12Q1/6809 ,  C12Q1/6886 ,  C12Q2600/106 ,  C12Q2600/112 ,  C12Q2600/136 ,  C12Q2600/178 ,  C12Q2525/207

    Abstract: It is disclosed herein that expression of microRNA-26 is decreased in hepatocellular (HCC) tumor tissue relative to non-cancerous tissue, and that a low level of microRNA-26 is associated with a poor clinical outcome. It is also disclosed herein that a low expression level of microRNA-26 is correlated with a favorable response to interferon (IFN) - α therapy in HCC patients. Thus, provided herein is a method of predicting the clinical outcome of a patient diagnosed with HCC comprising detecting the level of microRNA-26 expression in a sample obtained from the patient. Also provided is a method of selecting a patient diagnosed with HCC as a candidate for IFN-α therapy, comprising detecting the level of microRNA-26 expression in a sample obtained from the patient. A method of identifying therapeutic agents for the treatment of HCC, comprising screening candidate agents in vitro to select an agent that increases expression of microRNA-26 in HCC cells are also provided. Further provided are methods of treating a patient diagnosed with HCC and expressing a low level of miR-26, wherein treatment comprises IFN-α therapy.

    Abstract translation: 本文公开了相对于非癌组织，肝细胞（HCC）肿瘤组织中microRNA-26的表达降低，并且低水平的microRNA-26与不良临床结果相关。 本文还公开了微小RNA-26的低表达水平与对干扰素（IFN）的有利反应相关 - 在HCC患者中的治疗。 因此，本文提供了一种预测诊断为HCC的患者的临床结果的方法，包括检测从患者获得的样品中的microRNA-26表达水平。 还提供了选择被诊断为HCC的患者作为IFN-α治疗的候选者的方法，其包括检测从患者获得的样品中的microRNA-26表达水平。 还提供了鉴定用于治疗HCC的治疗剂的方法，其包括在体外筛选候选试剂以选择增加HCC细胞中微小RNA-26表达的试剂。 还提供了治疗诊断为HCC并表达低水平的miR-26的患者的方法，其中治疗包括IFN-α治疗。

Patent Agency Ranking